Synthesis and optimization of ceftriaxone-loaded solid lipid nanocarriers

Chemistry and Physics of Lipids

Volumn 200, Issue , 2016, Pages 126-132

  Kumar, Sandeep ^a   Bhanjana, Gaurav ^a   Kumar, Arvind ^a   Taneja, Kapila ^a   Dilbaghi, Neeraj ^a   Kim, Ki Hyun ^b  

^a GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

^b Hanyang University   (South Korea)

Author keywords

Antibacterial; Ceftriaxone sodium; Emulsification; Nanoformulation; Solid lipid nanoparticles

Indexed keywords

CEFTRIAXONE; SOLID LIPID NANOPARTICLE; DRUG CARRIER; LIPID; NANOPARTICLE;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG DELIVERY SYSTEM; EMULSION; ENCAPSULATION; ENTEROBACTER AEROGENES; IN VITRO STUDY; INFRARED SPECTROSCOPY; INHIBITION ZONE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PAENIBACILLUS POLYMYXA; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPONSE SURFACE METHOD; SURFACE PROPERTY; SUSTAINED DRUG RELEASE; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; CHEMISTRY;

CEFTRIAXONE; DRUG CARRIERS; LIPIDS; NANOPARTICLES; PARTICLE SIZE; SURFACE PROPERTIES;

EID: 84989841782     PISSN: 00093084     EISSN: 18732941     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2016.09.002     Document Type: Article

References (38)

1. Aditya, N., Ko, S., Solid lipid nanoparticles (SLNs): delivery vehicles for food bioactives. RSC Adv. 5 (2015), 30902–30911.
2. Attama, A.A., Müller-Goymann, C.C., Effect of beeswax modification on the lipid matrix and solid lipid nanoparticle crystallinity. Colloids Surf. A 315 (2008), 189–195.
3. Attama, A.A., Umeyor, C.E., The use of solid lipid nanoparticles for sustained drug release. Ther. Deliv. 6 (2015), 669–684.
4. Bargoni, A., Cavalli, R., Zara, G.P., Fundaro, A., Caputo, O., Gasco, M.R., Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II–tissue distribution. Pharm. Res. 43 (2001), 497–502.
5. Cacciatore, I., Ciulla, M., Fornasari, E., Marinelli, L., Di Stefano, A., Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases. Expert Opin. Drug Deliv. 13 (2016), 1121–1131.
6. Campos, E.V.R., de Oliveira, J.L., da Silva, C.M.D., Pascoli, M., Pasquoto, T., Lima, R., Abhilash, P.C., Fraceto, L.F., Polymeric and solid lipid nanoparticles for sustained release of carbendazim and tebuconazole in agricultural applications. Sci. Rep., 5, 2015, 10.1038/srep13809.
7. Cars, O., Hedin, A., Heddini, A., The global need for effective antibiotics moving towards concerted action. Drug Resist. Update 14 (2011), 68–69.
8. Cavalli, R., Zara, G.P., Caputo, O., Bargoni, A., Fundaro, A., Gasco, M.R., Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I—a pharmacokinetic study. Pharmacol. Res. 42 (2000), 541–545.
9. Cavalli, R., Gasco, M.R., Chetoni, P., Burgalassi, S., Saettone, M.F., Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int. J. Pharm. 238 (2002), 241–245.
10. File, T., Segreti, J., Dunbar, L., Player, R., Kohler, R., Williams, R., Kojak, C., Rubin, A., A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. Antimicrob. Agents Chemother. 41 (1997), 1965–1972.
11. Hu, L., Tang, X., Cui, F., Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. J. Pharm. Pharmacol. 56 (2004), 1527–1535.
12. Huh, A.J., Kwon, Y.J., Nanoantibiotics: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J. Control. Release 156 (2011), 128–145.
13. Kalhapure, R.S., Suleman, N., Mocktar, C., Seedat, N., Govender, T., Nanoengineered drug delivery systems for enhancing antibiotic therapy. J. Pharm. Sci. 104 (2015), 872–905.
14. Kapil, A., The challenge of antibiotic resistance: need to contemplate. Indian J. Med. Res. 121 (2005), 83–91.
15. Kaur, G., Mehta, S., Kumar, S., Bhanjana, G., Dilbaghi, N., Coencapsulation of hydrophobic and hydrophilic antituberculosis drugs in synergistic brij 96 microemulsions: a biophysical characterization. J. Pharm. Sci. 104 (2015), 2203–2212.
16. Kazemi, D., Salouti, M., Rostamizadeh, K., Zabihian, A., Development of gentamicin-loaded solid lipid nanoparticles: evaluation of drug release kinetic and antibacterial activity against staphylococcus aureus. IJPRI 7 (2014), 1–6.
17. Kumar, S., Bhanjana, G., Kumar, R., Dilbaghi, N., Synthesis, characterization and antimicrobial activity of nano titanium (IV) mixed ligand complex. Mater. Focus 2 (2013), 475–481.
18. Kumar, S., Bhanjana, G., Sharma, A., Sidhu, M., Dilbaghi, N., Synthesis, characterization and on field evaluation of pesticide loaded sodium alginate nanoparticles. Carbohydr. Polym. 101 (2014), 1061–1067.
19. Kumar, S., Bhanjana, G., Sharma, A., Sidhu, M., Dilbaghi, N., Herbicide loaded carboxymethyl cellulose nanocapsules as potential carrier in agrinanotechnology. Sci. Adv. Mater. 7 (2015), 1143–1148.
20. Kuo, Y.C., Chen, H.H., Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles. Int. J. Pharm. 365 (2009), 206–213.
21. Lim, S.B., Banerjee, A., Onyuksel, H., Improvement of drug safety by the use of lipid-based nanocarriers. J. Control. Release 163 (2012), 34–45.
22. Lu, Y.M., Huang, J.Y., Wang, H., Lou, X.F., Liao, M.H., Hong, L.J., Tao, R.R., Ahmed, M.M., Shan, C.L., Wang, X.L., Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles. Biomaterials 35 (2014), 530–537.
23. Manuja, A., Kumar, S., Dilbaghi, N., Bhanjana, G., Chopra, M., Kaur, H., Kumar, R., Manuja, B.K., Singh, S.K., Yadav, S.C., Quinapyramine sulfate-loaded sodium alginate nanoparticles show enhanced trypanocidal activity. Nanomedicine 9 (2014), 1625–1634.
24. Mehnert, W., Mäder, K., Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 47 (2001), 165–196.
25. Muller, R.H., Keck, C.M., Challenges and solutions for the delivery of biotech drugs – a review of drug nanocrystal technology and lipid nanoparticles. J. Biotechnol. 113 (2004), 151–170.
26. Muller, R.H., Radtke, M., Wissing, S.A., Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54 (2002), S131–S155.
27. Mussi, S.V., Silva, R.C., de Oliveira, M.C., Lucci, C.M., de Azevedo, R.B., Ferreira, L.A.M., New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles. Eur. J. Pharm. Sci. 48 (2013), 282–290.
28. Pelgrift, R.Y., Friedman, A.J., Nanotechnology as a therapeutic tool to combat microbial resistance. Adv. Drug Deliv. Rev. 65 (2013), 1803–1815.
29. Rohit, B., Pal, K.I., A method to prepare solid lipid nanoparticles with improved entrapment efficiency of hydrophilic drugs. Curr. Nanosci. 9 (2013), 211–220.
30. Schaad, U., Wedgwood-Krucko, J., Tschaeppeler, H., Reversible ceftriaxone-associated biliary pseudolithiasis In children. Lancet 332 (1988), 1411–1413.
31. Schafer-Korting, M., Mehnert, W., Korting, H.C., Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv. Drug Deliv. Rev. 59 (2007), 427–443.
32. Severino, P., Chaud, M.V., Shimojo, A., Antonini, D., Lancelloti, M., Santana, H.A., Souto, E.B., Sodium alginate-cross-linked polymyxin B sulphate-loaded solid lipid nanoparticles: antibiotic resistance tests and HaCat and NIH/3T3 cell viability studies. Colloids Surf. B 129 (2015), 191–197.
33. Sharma, A., Arya, D.K., Dua, M., Chhatwal, G.S., Johri, A.K., Nano-technology for targeted drug delivery to combat antibiotic resistance. Expert Opin. Drug Deliv. 9 (2012), 1325–1332.
34. Shiffman, M.L., Keith, F.B., Moore, E.W., Pathogenesis of ceftriaxone-associated biliary sludge. Gastroenterology 99 (1990), 1772–1778.
35. Shrimali, J.D., Patel, H.V., Gumber, M.R., Kute, V.B., Shah, P.R., Vanikar, A.V., Trivedi, H.L., Ceftriaxone induced immune hemolytic anemia with disseminated intravascular coagulation. Indian J. Crit. Care Med. 17 (2013), 394–395.
36. Subedi, R.K., Kang, K.W., Choi, H.K., Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur. J. Pharm. Sci. 37 (2009), 508–513.
37. WHO, 2014. http://www.who.int/mediacentre/news/releases/2014/amr-report/en/.
38. Xie, S., Zhu, L., Dong, Z., Wang, Y., Wang, X., Zhou, W., Preparation and evaluation of ofloxacin-loaded palmitic acid solid lipid nanoparticles. Int. J. Nanomed. 6 (2011), 547–555.